Cancer progress is mixed but trending positive despite significant challenges
Source: https://www.theguardian.com/profile/devi-sridhar. "Cancer is now a story of the good, the bad and the ugly – but also hope | Devi Sridhar | The Guardian." June 1, 2026. www.theguardian.com
The Gist
The author argues that while cancer presents serious challenges like rising rates in young people and healthcare shortages, the scientific advances in treatment are so significant that we should be optimistic. She believes the good news outweighs the bad.
Conclusion
While cancer presents complex challenges including rising rates in young people and healthcare capacity issues, the overall trajectory shows more good than bad, with significant treatment advances providing genuine reasons for optimism
Premises
- Cancer survival rates have dramatically improved for many types, with some cancers now having over 90% five-year survival rates
- New breakthrough treatments like daraxonrasib for pancreatic cancer and precision medicine approaches are revolutionizing care
- We're developing better targeted therapies that work for specific patient genetics rather than one-size-fits-all approaches
- There is a global shortage of cancer care workers (projected 100 million shortfall by 2050) limiting treatment capacity
- Cancer rates are rising in people under 50, with each generation having higher cancer risk than the previous one
- Treatment delays are common across healthcare systems, with most NHS trusts failing to meet 62-day treatment targets
- Environmental factors like processed foods, obesity, alcohol, and stress are contributing to increased cancer incidence
Assumptions
- Scientific progress in cancer treatment will continue at current or accelerated pace
- Survival rate improvements represent meaningful progress despite other challenges
- The author's personal experience with her father's cancer is representative of broader treatment advances
- Healthcare system capacity issues can be addressed without undermining treatment progress